Ashley E. Shay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ashley E. Shay has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Charles Nicholas Serhan
Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital and Harvard Medical School
4 shared publications - Jesper Z. Haeggström
Department of Medical Biochemistry and Biophysics, Division of Chemistry II, Karolinska Institutet, Stockholm, Sweden
2 shared publications - Nicos A. Petasis
Department of Chemistry and Loker Hydrocarbon Research Institute, University of Southern California, Los Angeles, CA 90089, USA
2 shared publications - Robert Nshimiyimana
Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
2 shared publications A. Rakian
Department of Applied Oral Science, The Forsyth Institute, Cambridge, MA, USA
1 shared publication- Alan K. Jarmusch
National Institute of Environmental Health Sciences
1 shared publication
Latest Publications
- Open Access
- 31 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Adaptation to cystine limitation stress confers a targetable lipid metabolism vulnerability in pancreatic ductal adenocarcinoma
Cystine/cysteine is critical for antioxidant response and sulfur metabolism in cancer cells and is one of the most depleted amino acids in the microenvironment of pancreatic ductal adenocarcinoma (PDAC). The effects of cystine limitation stress (CLS) on PDAC progression are poorly understood. Here we report that adaptation to CLS (CLSA) promotes PDAC cell proliferation and tumor growth through translational upregulation of the oxidative pentose phosphate pathway (OxPPP). OxPPP activates the de novo synthesis of nucleotides and fatty acids to support tumor growth. On the other hand, CLSA-mediated lipidomic reprogramming depends on triacylglycerides synthesis and lipid droplet formation to mitigate lipotoxicity. Through drug screening, we identify lomitapide as an inhibitor of CLSA PDAC tumor growth and a potent sensitizer of chemotherapy. Lomitapide inhibits triacylglycerides synthesis to interfere with CLSA and chemotherapy-induced lipidomic reprogramming. Taken together, we demonstrate that CLSA promotes PDAC tumor growth through metabolic reprogramming and lomitapide could be used to target the dysregulated lipid metabolism in PDAC.
- 31 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessAdaptation to cystine limitation stress confers a targetable lipid metabolism vulnerability in pancreatic ductal adenocarcinoma
Cystine/cysteine is critical for antioxidant response and sulfur metabolism in cancer cells and is one of the most depleted amino acids in the microenvironment of pancreatic ductal adenocarcinoma (PDAC). The effects of cystine limitation stress (CLS) on PDAC progression are poorly understood. Here we report that adaptation to CLS (CLSA) promotes PDAC cell proliferation and tumor growth through translational upregulation of the oxidative pentose phosphate pathway (OxPPP). OxPPP activates the de novo synthesis of nucleotides and fatty acids to support tumor growth. On the other hand, CLSA-mediated lipidomic reprogramming depends on triacylglycerides synthesis and lipid droplet formation to mitigate lipotoxicity. Through drug screening, we identify lomitapide as an inhibitor of CLSA PDAC tumor growth and a potent sensitizer of chemotherapy. Lomitapide inhibits triacylglycerides synthesis to interfere with CLSA and chemotherapy-induced lipidomic reprogramming. Taken together, we demonstrate that CLSA promotes PDAC tumor growth through metabolic reprogramming and lomitapide could be used to target the dysregulated lipid metabolism in PDAC.
- Open Access
- 23 October 2025
- Published by Springer Nature in Journal of Chemical Ecology
- Vol. 51 (6) , 1-12
Sequestration of plant defenses by spotted lanternfly (Lycorma delicatula) and effects on avian predators
Lycorma delicatula is a polyphagous phloem feeder, which is spreading rapidly in the U.S., and is a major threat to grapes, hops, and ornamentals. Among its hosts, L. delicatula prefers Ailanthus altissima , an invasive tree from which it sequesters toxins, including several quassinoid compounds. We tested how these defenses affected predation by birds of nymphal and adult L. delicatula . Freeze-killed nymphs of each instar were reared with or without access to A. altissima and placed into cups on top of nest boxes occupied by house wrens ( Troglodytes aedon ). House wrens ate or fed their chicks a greater proportion of L. delicatula nymphs that had not had access to A. altissima than the nymphs that had access to this host plant. Adult L. delicatula reared with or without access to A. altissima were ground up and incorporated into separate batches of suet that were placed into double sided feeders set up at different sites during the winter. Trail camera video was reviewed to record how many times birds pecked each suet cake. Birds pecked the suet containing L. delicatula reared without access to A. altissima significantly more frequently than the suet containing adults that had fed on A. altissima . Of the quassinoids sequestered by L. delicatula from phloem sap of A. altissima , ailanthone and four other quassinoids were identified and quantified in different tissues, with the highest concentrations in the salivary glands. Results suggest that sequestration of toxic chemicals from A. altissima provides some protection to L. delicatula from avian predators.
- 23 October 2025
- Published by Springer Nature in Journal of Chemical Ecology
- Vol. 51 (6) , 1-12
Open AccessSequestration of plant defenses by spotted lanternfly (Lycorma delicatula) and effects on avian predators
Lycorma delicatula is a polyphagous phloem feeder, which is spreading rapidly in the U.S., and is a major threat to grapes, hops, and ornamentals. Among its hosts, L. delicatula prefers Ailanthus altissima , an invasive tree from which it sequesters toxins, including several quassinoid compounds. We tested how these defenses affected predation by birds of nymphal and adult L. delicatula . Freeze-killed nymphs of each instar were reared with or without access to A. altissima and placed into cups on top of nest boxes occupied by house wrens ( Troglodytes aedon ). House wrens ate or fed their chicks a greater proportion of L. delicatula nymphs that had not had access to A. altissima than the nymphs that had access to this host plant. Adult L. delicatula reared with or without access to A. altissima were ground up and incorporated into separate batches of suet that were placed into double sided feeders set up at different sites during the winter. Trail camera video was reviewed to record how many times birds pecked each suet cake. Birds pecked the suet containing L. delicatula reared without access to A. altissima significantly more frequently than the suet containing adults that had fed on A. altissima . Of the quassinoids sequestered by L. delicatula from phloem sap of A. altissima , ailanthone and four other quassinoids were identified and quantified in different tissues, with the highest concentrations in the salivary glands. Results suggest that sequestration of toxic chemicals from A. altissima provides some protection to L. delicatula from avian predators.
- 18 April 2025
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 36 (5) , 926-929
Library Enabling Annotation of Botanical Natural Products (LEAFBot): An Open-Access Library of Mass Spectrometry Fragmentation Spectra for Plant Metabolites
Many existing mass spectral libraries focus on human or microbially derived molecules. Few plant-specific MS2 databases exist, making annotation of botanical samples difficult. To fill this gap in mass spectrometry data availability, the Library Enabling Annotation of Botanical Natural Products (LEAFBot) was constructed. Using a flow injection mass spectrometry method that allowed for rapid throughput data collection, the MS2 spectra of >300 pure botanical secondary metabolites were experimentally measured and complied into a single library housed in the Global Natural Products Social Molecular Networking (GNPS) spectral database. Of these compounds, over 20% were not present in the existing GNPS database, and 11% were not present in any of three main mass spectral databases (GNPS, Metlin, and MassBank). Additionally, LEAFBot contains a wider range of adducts compared to other plant-based mass spectral libraries, enabling more effective annotation of unknown features. The LEAFBot database represents a new resource to the mass spectrometry and metabolomics community seeking to characterize plant-based samples. The possibility of searching against a taxonomically specific library decreases the likelihood of false positives in database searches, and the ease of adding new spectra, following procedures outlined herein, will enable community-lead expansion of the database.
- 18 April 2025
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 36 (5) , 926-929
Library Enabling Annotation of Botanical Natural Products (LEAFBot): An Open-Access Library of Mass Spectrometry Fragmentation Spectra for Plant Metabolites
Many existing mass spectral libraries focus on human or microbially derived molecules. Few plant-specific MS2 databases exist, making annotation of botanical samples difficult. To fill this gap in mass spectrometry data availability, the Library Enabling Annotation of Botanical Natural Products (LEAFBot) was constructed. Using a flow injection mass spectrometry method that allowed for rapid throughput data collection, the MS2 spectra of >300 pure botanical secondary metabolites were experimentally measured and complied into a single library housed in the Global Natural Products Social Molecular Networking (GNPS) spectral database. Of these compounds, over 20% were not present in the existing GNPS database, and 11% were not present in any of three main mass spectral databases (GNPS, Metlin, and MassBank). Additionally, LEAFBot contains a wider range of adducts compared to other plant-based mass spectral libraries, enabling more effective annotation of unknown features. The LEAFBot database represents a new resource to the mass spectrometry and metabolomics community seeking to characterize plant-based samples. The possibility of searching against a taxonomically specific library decreases the likelihood of false positives in database searches, and the ease of adding new spectra, following procedures outlined herein, will enable community-lead expansion of the database.
- Open Access
- 5 April 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (5) , 107259
Selenoprotein I is indispensable for ether lipid homeostasis and proper myelination
- 5 April 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (5) , 107259
Open AccessSelenoprotein I is indispensable for ether lipid homeostasis and proper myelination
- 16 July 2022
- Published by Elsevier in Biochemical Pharmacology
- Vol. 203, 115181
A newly synthesized 17-epi-NeuroProtectin D1/17-epi-Protectin D1: Authentication and functional regulation of Inflammation-Resolution
- 16 July 2022
- Published by Elsevier in Biochemical Pharmacology
- Vol. 203, 115181
A newly synthesized 17-epi-NeuroProtectin D1/17-epi-Protectin D1: Authentication and functional regulation of Inflammation-Resolution
- 15 April 2022
- Published by SAGE Publications in Journal of Dental Research
- Vol. 101 (10) , 1205-1213
Periodontal Stem Cells Synthesize Maresin Conjugate in Tissue Regeneration 3
Periodontal disease is a significant public health problem worldwide. Excess unresolved chronic inflammation destroys the periodontal tissues that surround and support the teeth, and efforts to control inflammation by removal of bacterial deposits on the teeth have limited long-term impact. Likewise, procedures aimed at regeneration of the periodontal tissues have shown limited success. Recent advances in stem cell research have shown promising novel prospects for the use of periodontal ligament stem cells (PDLSCs) in tissue regeneration; however, control of inflammation remains a barrier. Human PDLSCs have been shown to release specialized proresolving lipid mediators (SPMs) that modulate the immune response and promote resolution of inflammation, tissue repair, and regeneration. Studies on stem cell biology in periodontology have also been limited by the lack of a good large animal model. Herein, we describe PDLSC biology of the Yorkshire pig (pPDLSCs). pPDLSCs were isolated and characterized. Using lipid mediator profiling, we demonstrate for the first time that pPDLSCs biosynthesize cysteinyl-containing SPMs (cys-SPMs), specifically, maresin conjugates in tissue regeneration 3 (MCTR3) and its authentication using liquid chromatography/tandem mass spectrometry. The exogenous addition of the n-3 precursor docosahexaenoic acid enhances MCTR3 biosynthesis. Using immunocytochemistry, we show that pPDLSCs express 4 of the SPM biosynthetic pathway enzymes necessary for SPM biosynthesis, including 5-lipoxygenase, 12-lipoxygenase, and 15-lipoxygenase-1. In addition, we identified and quantified the cytokine/chemokine profile of pPDLSCs using a 13-plex immunology multiplex assay and found that the pretreatment of pPDLSCs with MCTR3 in an inflammatory environment reduced the production of acute and chronic proinflammatory cytokines/chemokines. Together, these results suggest that enhancing resolution of inflammation pathways and mediators may be a possible key early event in predictable periodontal regeneration.
- 15 April 2022
- Published by SAGE Publications in Journal of Dental Research
- Vol. 101 (10) , 1205-1213
Periodontal Stem Cells Synthesize Maresin Conjugate in Tissue Regeneration 3
Periodontal disease is a significant public health problem worldwide. Excess unresolved chronic inflammation destroys the periodontal tissues that surround and support the teeth, and efforts to control inflammation by removal of bacterial deposits on the teeth have limited long-term impact. Likewise, procedures aimed at regeneration of the periodontal tissues have shown limited success. Recent advances in stem cell research have shown promising novel prospects for the use of periodontal ligament stem cells (PDLSCs) in tissue regeneration; however, control of inflammation remains a barrier. Human PDLSCs have been shown to release specialized proresolving lipid mediators (SPMs) that modulate the immune response and promote resolution of inflammation, tissue repair, and regeneration. Studies on stem cell biology in periodontology have also been limited by the lack of a good large animal model. Herein, we describe PDLSC biology of the Yorkshire pig (pPDLSCs). pPDLSCs were isolated and characterized. Using lipid mediator profiling, we demonstrate for the first time that pPDLSCs biosynthesize cysteinyl-containing SPMs (cys-SPMs), specifically, maresin conjugates in tissue regeneration 3 (MCTR3) and its authentication using liquid chromatography/tandem mass spectrometry. The exogenous addition of the n-3 precursor docosahexaenoic acid enhances MCTR3 biosynthesis. Using immunocytochemistry, we show that pPDLSCs express 4 of the SPM biosynthetic pathway enzymes necessary for SPM biosynthesis, including 5-lipoxygenase, 12-lipoxygenase, and 15-lipoxygenase-1. In addition, we identified and quantified the cytokine/chemokine profile of pPDLSCs using a 13-plex immunology multiplex assay and found that the pretreatment of pPDLSCs with MCTR3 in an inflammatory environment reduced the production of acute and chronic proinflammatory cytokines/chemokines. Together, these results suggest that enhancing resolution of inflammation pathways and mediators may be a possible key early event in predictable periodontal regeneration.
- 15 December 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (51)
Human leukocytes selectively convert 4 S ,5 S -epoxy-resolvin to resolvin D3, resolvin D4, and a cys-resolvin isomer
Significance: The resolution of the acute inflammatory response is an active, highly organized process essential for tissue regeneration, wound healing, and the return to homeostasis that involves specialized proresolving mediators (SPMs). The elucidation of mediators that play roles in these processes is of general interest since many widely occurring diseases display unresolved inflammation in their pathobiology. Here, we document the pivotal role of 4 S ,5 S -epoxy-resolvin as an intermediate in the biosynthesis of resolvin D3 and resolvin D4 and identified a unique cysteinyl-resolvin isomer that is biosynthesized in a cell type–specific manner. Results from cell- and model organism–based systems each defined the potent bioactivity of the cysteinyl-resolvin isomer.
- 15 December 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (51)
Human leukocytes selectively convert 4 S ,5 S -epoxy-resolvin to resolvin D3, resolvin D4, and a cys-resolvin isomer
Significance: The resolution of the acute inflammatory response is an active, highly organized process essential for tissue regeneration, wound healing, and the return to homeostasis that involves specialized proresolving mediators (SPMs). The elucidation of mediators that play roles in these processes is of general interest since many widely occurring diseases display unresolved inflammation in their pathobiology. Here, we document the pivotal role of 4 S ,5 S -epoxy-resolvin as an intermediate in the biosynthesis of resolvin D3 and resolvin D4 and identified a unique cysteinyl-resolvin isomer that is biosynthesized in a cell type–specific manner. Results from cell- and model organism–based systems each defined the potent bioactivity of the cysteinyl-resolvin isomer.
- 6 March 2021
- Published by Elsevier in The American Journal of Pathology
- Vol. 191 (6) , 1049-1063
PCTR1 Enhances Repair and Bacterial Clearance in Skin Wounds
- 6 March 2021
- Published by Elsevier in The American Journal of Pathology
- Vol. 191 (6) , 1049-1063
PCTR1 Enhances Repair and Bacterial Clearance in Skin Wounds
- Open Access
- 5 October 2019
- Published by Wiley in The FASEB Journal
- Vol. 33 (12) , 13794-13807
Biosynthetic metabolomes of cysteinyl‐containing immunoresolvents
Resolution of inflammation is an active process regulated by specialized proresolving mediators where we identified 3 new pathways producing allylic epoxide‐derived mediators that stimulate regeneration [ i.e. , peptido‐conjugates in tissue regeneration (CTRs)]. Here, using self‐limited Escherichia coli peritonitis in mice, we identified endogenous maresin (MaR) CTR (MCTR), protectin (PD) CTR (PCTR), and resolvin CTR in infectious peritoneal exudates and distal spleens, as well as investigated enzymes involved in their biosynthesis. PCTRs were identified to be temporally regulated in peritoneal exudates and spleens. PCTR1 and MCTR1 were each produced by human recombinant leukotriene (LT) C 4 synthase (LTC 4 S) and glutathione S‐transferases (GSTs) [microsomal GST (mGST)2, mGST3, and GST‐μ (GSTM)4] from their epoxide precursors [16 S ,17 S ‐epoxy‐PD (ePD) and 13 S ,14 S ‐epoxy‐MaR (eMaR)], with preference for GSTM4. Both eMaR and ePD inhibited LTB4 production by LTA 4 hydrolase. LTC 4 S, mGST2, mGST3, and GSTM4 were each expressed in human M1‐ and M2‐like macrophages where LTC 4 S inhibition increased CTRs. Finally, PCTR1 showed potent analgesic action. These results demonstrate CTR biosynthesis in mouse peritonitis, human spleens, and human macrophages, as well as identification of key enzymes in these pathways. Moreover, targeting LTC 4 S increases CTR metabolomes, giving a new strategy to stimulate resolution and tissue regeneration.—Jouvene, C. C., Shay, A. E., Soens, M. A., Norris, P. C., Haeggström, J. Z., Serhan, C. N. Biosynthetic metabolomes of cysteinyl‐containing immunoresolvents. FASEB J. 33, 13794‐13807 (2019). www.fasebj.org
- 5 October 2019
- Published by Wiley in The FASEB Journal
- Vol. 33 (12) , 13794-13807
Open AccessBiosynthetic metabolomes of cysteinyl‐containing immunoresolvents
Resolution of inflammation is an active process regulated by specialized proresolving mediators where we identified 3 new pathways producing allylic epoxide‐derived mediators that stimulate regeneration [ i.e. , peptido‐conjugates in tissue regeneration (CTRs)]. Here, using self‐limited Escherichia coli peritonitis in mice, we identified endogenous maresin (MaR) CTR (MCTR), protectin (PD) CTR (PCTR), and resolvin CTR in infectious peritoneal exudates and distal spleens, as well as investigated enzymes involved in their biosynthesis. PCTRs were identified to be temporally regulated in peritoneal exudates and spleens. PCTR1 and MCTR1 were each produced by human recombinant leukotriene (LT) C 4 synthase (LTC 4 S) and glutathione S‐transferases (GSTs) [microsomal GST (mGST)2, mGST3, and GST‐μ (GSTM)4] from their epoxide precursors [16 S ,17 S ‐epoxy‐PD (ePD) and 13 S ,14 S ‐epoxy‐MaR (eMaR)], with preference for GSTM4. Both eMaR and ePD inhibited LTB4 production by LTA 4 hydrolase. LTC 4 S, mGST2, mGST3, and GSTM4 were each expressed in human M1‐ and M2‐like macrophages where LTC 4 S inhibition increased CTRs. Finally, PCTR1 showed potent analgesic action. These results demonstrate CTR biosynthesis in mouse peritonitis, human spleens, and human macrophages, as well as identification of key enzymes in these pathways. Moreover, targeting LTC 4 S increases CTR metabolomes, giving a new strategy to stimulate resolution and tissue regeneration.—Jouvene, C. C., Shay, A. E., Soens, M. A., Norris, P. C., Haeggström, J. Z., Serhan, C. N. Biosynthetic metabolomes of cysteinyl‐containing immunoresolvents. FASEB J. 33, 13794‐13807 (2019). www.fasebj.org